Cannabix Technologies Inc (BLOZF)

OTHER OTC:BLOZF

BLOZF

Cannabix Technologies

RESEARCH TOOLSreports

Cannabix Technologies (BLOZF) Price & Analysis

Compare

399 Followers

BLOZF Stock Chart & Stats

$0.44

-$0.01(-6.26%)

At close: Jan 08 4:00 PM EST

$0.44

-$0.01(-6.26%)

Day’s Range― - ―

52-Week Range$0.33 - $0.68

Previous CloseN/A

Volume94.05K

Average Volume (3M)115.81K

Market Cap

$62.52M

Enterprise Value$88.63M

Total Cash (Recent Filing)$1.60M

Total Debt (Recent Filing)$88.43K

Price to Earnings (P/E)―

Beta0.31

Next Earnings

Mar 25, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)>-0.01

Shares Outstanding121,074,104

10 Day Avg. Volume123,087

30 Day Avg. Volume115,812

Financial Highlights & Ratios

PEG Ratio-0.30

Price to Book (P/B)27.07

Price to Sales (P/S)0.00

P/FCF Ratio-37.13

Enterprise Value/Market Cap1.42

Enterprise Value/Revenue720.38

Enterprise Value/Gross Profit-1.06K

Enterprise Value/Ebitda-14.43

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

Bulls Say, Bears Say

Bulls Say

Low Leverage / Modest DebtLow absolute debt and a very low debt-to-equity ratio materially reduce near-term solvency risk and interest burden. This balance-sheet conservatism gives the company more strategic flexibility to pursue R&D, partnerships or staged commercialization without immediate refinancing pressure.

Niche Breath-testing Technology FocusA focused product strategy on breath-based cannabis and alcohol detection addresses regulatory and safety needs across law enforcement, workplace testing and consumer markets. This specialized niche creates a defensible product roadmap and clear addressable markets if technical and regulatory validation are achieved.

Signs Of Improving Free Cash FlowPeriodic improvements in free cash flow indicate the company may be making operational progress or cost efficiencies. Sustained improvement would reduce funding needs, extend runway for commercialization, and make partnerships or modest capital raises less dilutive over the medium term.

Bears Say

Minimal Revenue, Deep LossesThe company remains far from commercial scale, generating negligible revenue while incurring significant operating losses. This structural shortfall shows product-market adoption is not yet established, making sustained profitability contingent on successful commercialization or new revenue streams.

Persistent Negative Cash Flow And BurnOngoing operating and free cash outflows create a durable financing need that can force dilution, distract management, or constrain investment in product development and commercialization. Continued negative cash flow increases execution risk unless offset by partners or new funding sources.

Erosion Of Equity And Negative ReturnsMaterial declines in equity and persistently negative ROE signal shareholder value erosion and likely dilution from financing. This weakens financial flexibility, elevates cost of capital over time, and can hamper the company's ability to secure strategic partners or attract long-term investors.

Cannabix Technologies News

Cannabix Lands First Commercial Sale of Marijuana Breath Test to Major Construction Firm

Cannabix Technologies ( ($TSE:BLO) ) just unveiled an update. Cannabix Technologies has recorded its first commercial sale of...

6d ago

Cannabix launches commercial marijuana breath test targeting recent cannabis use

The latest update is out from Cannabix Technologies ( ($TSE:BLO) ). Cannabix Technologies has begun a phased commercial...

9d ago

Cannabix Technologies Raises C$700,000 in Non-Brokered Private Placement

Cannabix Technologies ( ($TSE:BLO) ) just unveiled an update. Cannabix Technologies has closed a non-brokered private placement, raising...

29d ago

Cannabix Marijuana Breath Test Lands Cover Spot in AlcoPro’s 2026 Catalogue

The latest update is out from Cannabix Technologies ( ($TSE:BLO) ). Cannabix Technologies’ Marijuana Breath Test (MBT) has...

2M ago

Cannabix Wins First International BreathLogix Order, Scraps Planned Financing

Cannabix Technologies ( ($TSE:BLO) ) has issued an announcement. Cannabix Technologies has secured its first international distributor order...

3M ago

Cannabix Technologies’ Marijuana Breath Test Achieves Key Regulatory Milestone

Cannabix Technologies ( ($TSE:BLO) ) just unveiled an announcement. Cannabix Technologies Inc. announced a significant milestone for its...

4M ago

Cannabix Technologies Expands Maritime Market with Repeat BreathLogix Order

Cannabix Technologies ( ($TSE:BLO) ) has provided an update. Cannabix Technologies has secured a second sales agreement for...

4M ago

Cannabix Technologies Launches Private Placement to Raise Up to $2 Million

Cannabix Technologies ( ($TSE:BLO) ) has shared an update. Cannabix Technologies announced a non-brokered private placement to raise...

5M ago

Cannabix Technologies Secures Patent for Contactless Breath Analysis Innovation

Cannabix Technologies ( ($TSE:BLO) ) just unveiled an announcement. Cannabix Technologies Inc. has been granted a patent by...

5M ago

Cannabix Technologies Grants Incentive Stock Options

The latest update is out from Cannabix Technologies ( ($TSE:BLO) ). Cannabix Technologies Inc. has announced the granting...

5M ago

BLOZF FAQ

What was Cannabix Technologies Inc’s price range in the past 12 months?

Cannabix Technologies Inc lowest stock price was $0.33 and its highest was $0.68 in the past 12 months.

What is Cannabix Technologies Inc’s market cap?

Cannabix Technologies Inc’s market cap is $62.52M.

When is Cannabix Technologies Inc’s upcoming earnings report date?

Cannabix Technologies Inc’s upcoming earnings report date is Mar 25, 2026 which is today.

How were Cannabix Technologies Inc’s earnings last quarter?

Cannabix Technologies Inc released its earnings results on Dec 30, 2025. The company reported -$0.005 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.005.

Is Cannabix Technologies Inc overvalued?

According to Wall Street analysts Cannabix Technologies Inc’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Cannabix Technologies Inc pay dividends?

Cannabix Technologies Inc does not currently pay dividends.

What is Cannabix Technologies Inc’s EPS estimate?

Cannabix Technologies Inc’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Cannabix Technologies Inc have?

Cannabix Technologies Inc has 121,074,104 shares outstanding.

What happened to Cannabix Technologies Inc’s price movement after its last earnings report?

Cannabix Technologies Inc reported an EPS of -$0.005 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -0.473%.

Which hedge fund is a major shareholder of Cannabix Technologies Inc?

Currently, no hedge funds are holding shares in BLOZF

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Cannabix Technologies Stock Smart Score

Outperform

Fundamentals

Return on Equity

-259.71%

Trailing 12-Months

Asset Growth

-41.52%

Trailing 12-Months

Top Smart Score Stocks >

Company Description

Cannabix Technologies Inc

Cannabix Technologies Inc., a technology company, develops marijuana breathalyzer for employers, law enforcement, governments, and public in North America. It develops tetrahydrocannabinol breath analyzers, a point of care breath testing tool for the rapid detection of recent cannabis use, as well as breath collection units. The company was formerly known as West Point Resources Inc. and changed its name to Cannabix Technologies Inc. in August 2014. Cannabix Technologies Inc. was incorporated in 2011 and is based in Burnaby, Canada.